Your browser doesn't support javascript.
loading
Optical coherence tomography predictors of clinical outcomes after stent implantation: the ILUMIEN IV trial.
Landmesser, Ulf; Ali, Ziad A; Maehara, Akiko; Matsumura, Mitsuaki; Shlofmitz, Richard A; Guagliumi, Giulio; Price, Matthew J; Hill, Jonathan M; Akasaka, Takashi; Prati, Francesco; Bezerra, Hiram G; Wijns, William; Leistner, David; Canova, Paolo; Alfonso, Fernando; Fabbiocchi, Franco; Calligaris, Giuseppe; Oemrawsingh, Rohit M; Achenbach, Stephan; Trani, Carlo; Singh, Balbir; McGreevy, Robert J; McNutt, Robert W; Ying, Shih-Wa; Buccola, Jana; Stone, Gregg W.
Afiliação
  • Landmesser U; Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum Charité, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Ali ZA; Berlin Institute of Health, Berlin, Germany.
  • Maehara A; German Centre for Cardiovascular Research, Berlin, Germany.
  • Matsumura M; St. Francis Hospital, Roslyn, NY, USA.
  • Shlofmitz RA; Cardiovascular Research Foundation, New York, NY, USA.
  • Guagliumi G; Cardiovascular Research Foundation, New York, NY, USA.
  • Price MJ; Center for Interventional Cardiovascular Care, Columbia University, New York, NY, USA.
  • Hill JM; Cardiovascular Research Foundation, New York, NY, USA.
  • Akasaka T; St. Francis Hospital, Roslyn, NY, USA.
  • Prati F; IRCCS Galeazzi Sant'Ambrogio Hospital, Milan, Italy.
  • Bezerra HG; Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, CA, USA.
  • Wijns W; Royal Brompton Hospital, London, UK.
  • Leistner D; Wakayama Medical University, Wakayama, Japan.
  • Canova P; Saint Camillus International University of Health Sciences, CLI Foundation, Rome, Italy.
  • Alfonso F; Tampa General Hospital, Tampa, FL.
  • Fabbiocchi F; The Lambe Institute for Translational Medehance Spicine and Curam, University of Galway, Galway, Ireland.
  • Calligaris G; Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany.
  • Oemrawsingh RM; German Center for Cardiovascular Research (DZHK) Partner Site RheinMain, Frankfurt, Germany.
  • Achenbach S; Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Trani C; Cardiology Department, Hospital Universitario de La Princesa, CIBERCV, IIS-IP, Madrid, Spain.
  • Singh B; IRCCS Galeazzi Sant'Ambrogio Hospital, Milan, Italy.
  • McGreevy RJ; Department of Cardiovascular Sciences, University of Milan, Milano, Italy.
  • McNutt RW; Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands.
  • Ying SW; Department of Cardiology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Buccola J; Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.
  • Stone GW; Max Super Specialty Hospital, Saket, New Delhi, India.
Eur Heart J ; 2024 Aug 28.
Article em En | MEDLINE | ID: mdl-39196989
ABSTRACT
BACKGROUND AND

AIMS:

Observational registries have suggested that optical coherence tomography (OCT) imaging-derived parameters may predict adverse events after drug-eluting stent (DES) implantation. The present analysis sought to determine the OCT predictors of clinical outcomes from the large-scale ILUMIEN IV trial.

METHODS:

ILUMIEN IV was a prospective, single-blind trial of 2487 patients with diabetes or high-risk lesions randomized to OCT-guided versus angiography-guided DES implantation. All patients underwent final OCT imaging (blinded in the angiography-guided arm). From more than 20 candidates, the independent OCT predictors of 2-year target lesion failure (TLF; the primary endpoint), cardiac death or target-vessel myocardial infarction (TV-MI), ischaemia-driven target lesion revascularization (ID-TLR), and stent thrombosis were analysed by multivariable Cox proportional hazard regression in single treated lesions.

RESULTS:

A total of 2128 patients had a single treated lesion with core laboratory-analysed final OCT. The 2-year Kaplan-Meier rates of TLF, cardiac death or TV-MI, ID-TLR, and stent thrombosis were 6.3% (n = 130), 3.3% (n = 68), 4.3% (n = 87), and 0.9% (n = 18), respectively. The independent predictors of 2-year TLF were a smaller minimal stent area (per 1 mm2 increase hazard ratio 0.76, 95% confidence interval 0.68-0.89, P < .0001) and proximal edge dissection (hazard ratio 1.77, 95% confidence interval 1.20-2.62, P = .004). The independent predictors of cardiac death or TV-MI were smaller minimal stent area and longer stent length; of ID-TLR were smaller intra-stent flow area and proximal edge dissection; and of stent thrombosis was smaller minimal stent expansion.

CONCLUSIONS:

In the ILUMIEN IV trial, the most important OCT-derived post-DES predictors of both safety and effectiveness outcomes were parameters related to stent area, expansion and flow, proximal edge dissection, and stent length.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article